AR026764A1 - Tratamiento enzimatico para infecciones. - Google Patents
Tratamiento enzimatico para infecciones.Info
- Publication number
- AR026764A1 AR026764A1 ARP000106541A ARP000106541A AR026764A1 AR 026764 A1 AR026764 A1 AR 026764A1 AR P000106541 A ARP000106541 A AR P000106541A AR P000106541 A ARP000106541 A AR P000106541A AR 026764 A1 AR026764 A1 AR 026764A1
- Authority
- AR
- Argentina
- Prior art keywords
- infections
- enzymes
- enzymatic treatment
- treatment
- infective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Husbandry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Enzimas de una cla se particular, caracterizada por su capacidad para clivar un enlace responsable de la liberacion de una proteína i un carbohidrato de lasuperficie celular, que no contiene un agente antiinfeccioso, que presentan una actividad antii nfecciosa significativa. Cuando se administran por vía oral,estas enzimas sone fectivas, por ejemplo, en el tratamiento de infecciones del tracto digestivo en seres humanos y en animales. En este ultimo caso, hayventajas de una mayor tasa de crecimie nto, eficacia alimentaria y estado de salud general.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16993599P | 1999-12-10 | 1999-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026764A1 true AR026764A1 (es) | 2003-02-26 |
Family
ID=22617824
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000106541A AR026764A1 (es) | 1999-12-10 | 2000-12-07 | Tratamiento enzimatico para infecciones. |
ARP130100218A AR089799A2 (es) | 1999-12-10 | 2013-01-24 | Composicion que comprende enzimas y usos para la fabricacion de una composicion para tratar o disminuir el riesgo de infecciones del tracto digestivo |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130100218A AR089799A2 (es) | 1999-12-10 | 2013-01-24 | Composicion que comprende enzimas y usos para la fabricacion de una composicion para tratar o disminuir el riesgo de infecciones del tracto digestivo |
Country Status (31)
Country | Link |
---|---|
US (2) | US6780628B2 (es) |
EP (1) | EP1239872B1 (es) |
JP (1) | JP4871473B2 (es) |
KR (1) | KR100639746B1 (es) |
CN (3) | CN101327320A (es) |
AR (2) | AR026764A1 (es) |
AT (1) | ATE481981T1 (es) |
AU (1) | AU782831B2 (es) |
BR (1) | BRPI0016231B8 (es) |
CA (1) | CA2394856C (es) |
CL (1) | CL2008000057A1 (es) |
CO (1) | CO5280226A1 (es) |
CR (1) | CR6674A (es) |
CZ (1) | CZ304925B6 (es) |
DE (1) | DE60045010D1 (es) |
DK (1) | DK1239872T3 (es) |
ES (1) | ES2353371T3 (es) |
HU (1) | HU230301B1 (es) |
IL (2) | IL150048A0 (es) |
IN (1) | IN247731B (es) |
MX (1) | MX264033B (es) |
MY (1) | MY124714A (es) |
NZ (1) | NZ519404A (es) |
PH (1) | PH12000003381B1 (es) |
PL (1) | PL203054B1 (es) |
PT (1) | PT1239872E (es) |
RU (1) | RU2272419C2 (es) |
SK (1) | SK287956B6 (es) |
TW (1) | TWI255189B (es) |
UA (1) | UA78486C2 (es) |
WO (1) | WO2001041785A2 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78486C2 (uk) | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти) |
US7247299B2 (en) * | 2002-11-27 | 2007-07-24 | Kemin Industries, Inc. | Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens |
US8394379B2 (en) * | 2003-05-15 | 2013-03-12 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US7566447B2 (en) * | 2003-05-15 | 2009-07-28 | Iogenetics, Llc | Biocides |
US20050014932A1 (en) * | 2003-05-15 | 2005-01-20 | Iogenetics, Llc | Targeted biocides |
US8703134B2 (en) | 2003-05-15 | 2014-04-22 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US8431123B2 (en) | 2003-07-14 | 2013-04-30 | Cls Therapeutics Limited | Method for treating systemic bacterial, fungal and protozoan infection |
US8388951B2 (en) | 2003-07-14 | 2013-03-05 | Cls Therapeutics Limited | Method for treating systemic DNA mutation disease |
US8710012B2 (en) | 2003-07-14 | 2014-04-29 | Cls Therapeutics Limited | Method for treating oncological diseases |
AU2005332655A1 (en) * | 2004-10-20 | 2006-12-14 | Iogenetics, Llc | Biocides |
EP1880733A4 (en) | 2005-04-25 | 2009-08-12 | Genkin Dmitry Dmitrievich | METHOD FOR EXTENDING THE LIFE OF A HUMAN AND ANIMALS |
BRPI0620155B1 (pt) * | 2005-12-15 | 2015-07-21 | Lilly Co Eli | Composição adequada para administração oral a um animal compreendendo uma enzima redutora de estresse imunológico em um veículo aceitável por via oral |
JP5372769B2 (ja) | 2006-11-28 | 2013-12-18 | シーエルエス セラピューティック リミティド | 組織の細胞外間隙においてデオキシリボ核酸の量が増量することに関連するヒトの病気の治療方法及び該方法を実施するための医薬製剤 |
EP2164862B1 (en) * | 2007-06-08 | 2015-07-22 | Australian Poultry CRC Pty Ltd | Clostridial toxin netb |
JP5427789B2 (ja) * | 2007-12-20 | 2014-02-26 | ダニスコ・ユーエス・インク | バイオフィルムの酵素的予防及び制御 |
ES2645062T3 (es) * | 2008-02-08 | 2017-12-04 | Prothera, Inc. | Inhibición y tratamiento de biopelículas gastrointestinales |
PL2814331T3 (pl) | 2012-02-16 | 2019-04-30 | Elanco Inc | Sposoby i kompozycje do zmniejszenia wpływu odpadów zwierzęcych na środowisko |
US10617743B2 (en) | 2014-06-19 | 2020-04-14 | Cls Therapeutics Limited | Method to improve safety and efficacy of anti-cancer therapy |
TWI656872B (zh) | 2014-11-13 | 2019-04-21 | 美商益農美國公司 | 甲基鹽黴素於豬飼料中之抗病毒效果 |
RU2726131C2 (ru) | 2015-05-22 | 2020-07-09 | Дмитрий Дмитриевич Генкин | Внеклеточная днк в качестве терапевтической мишени при нейродегенерации |
CN106119221A (zh) * | 2016-06-28 | 2016-11-16 | 浙江省农业科学院 | 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用 |
CN106318925B (zh) * | 2016-08-19 | 2021-04-02 | 浙江省农业科学院 | 利用枯草芽孢杆菌高效表达pi-plc基因的方法 |
CN106615691B (zh) * | 2016-10-11 | 2019-07-02 | 上海国龙生物技术集团有限公司 | 一种抗感染酶复合剂及其在饲料中的应用 |
US10501730B2 (en) * | 2017-05-30 | 2019-12-10 | Ab Enzymes Oy | Mannanase variants |
AU2019209770A1 (en) | 2018-01-16 | 2020-09-03 | Cls Therapeutics Limited | Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity |
US20210011027A1 (en) * | 2018-03-02 | 2021-01-14 | Evonik Operations Gmbh | In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin |
RU2720471C1 (ru) * | 2019-03-21 | 2020-04-30 | Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" | Кормовая добавка для цыплят-бройлеров |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1509866A (en) | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
JPS5534039A (en) | 1978-08-30 | 1980-03-10 | Hiroo Ikezawa | Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis |
US4891319A (en) | 1985-07-09 | 1990-01-02 | Quadrant Bioresources Limited | Protection of proteins and the like |
US4877738A (en) | 1986-07-25 | 1989-10-31 | Wisconsin Alumni Research Foundation | Biological control of damping off and root rot and inoculum preparation therefor |
US5049379A (en) | 1987-07-27 | 1991-09-17 | Wisconsin Alumni Research Foundation | Fungicidal toxin and method and inoculum for controlling root rot and damping off |
JPH0338530A (ja) * | 1989-07-03 | 1991-02-19 | Ajinomoto Co Inc | 抗真菌剤 |
US5487897A (en) * | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
ATE161395T1 (de) * | 1990-05-29 | 1998-01-15 | Chemgen Corp | Hemicellulasezusatz geeignet zum erhöhen des energiewirkungsgrads von hemicellulose enthaltenden nahrungsmitteln und tierfutter |
EP0477739A3 (en) * | 1990-09-27 | 1992-12-09 | F. Hoffmann-La Roche Ag | Glycosyl-phosphatidylinositol-specific phospholipase d |
JPH07184642A (ja) * | 1993-12-27 | 1995-07-25 | Toagosei Co Ltd | ホスホリパーゼcの生産方法 |
EP0743017B1 (en) * | 1995-05-15 | 2004-09-29 | DSM IP Assets B.V. | Application of phospholipases in animal feed |
NL1003096C2 (nl) * | 1995-05-15 | 1996-11-19 | Gist Brocades Bv | Application of phospholipases in animal feed. |
JPH08332032A (ja) * | 1995-06-12 | 1996-12-17 | Showa Denko Kk | 動物経口物用酵素剤及びその用途 |
JP3914585B2 (ja) * | 1995-10-19 | 2007-05-16 | イーエヌ大塚製薬株式会社 | マクロファージ一酸化窒素産生亢進剤 |
US6162473A (en) * | 1996-05-03 | 2000-12-19 | Chemgen Corporation | Hemicellulase use in feeds with low caloric content |
CN1092495C (zh) * | 1996-05-03 | 2002-10-16 | 开姆根有限公司 | 半纤维素酶在低热焓饲料中的应用 |
JPH1045581A (ja) * | 1996-07-29 | 1998-02-17 | Hideyo Yamaguchi | 好中球機能低下抑制剤又は感染防御剤 |
EP0948608A1 (en) * | 1996-10-31 | 1999-10-13 | Novo Nordisk A/S | Novel phospholipase, production and use thereof |
AU753232B2 (en) | 1998-10-15 | 2002-10-10 | Dsm N.V. | Antimicrobial enzymes in animal feed |
UA78486C2 (uk) | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти) |
US20020116028A1 (en) * | 2001-02-20 | 2002-08-22 | Wilson Greatbatch | MRI-compatible pacemaker with pulse carrying photonic catheter providing VOO functionality |
-
2000
- 2000-08-12 UA UA2002075677A patent/UA78486C2/uk unknown
- 2000-12-07 CO CO00093684A patent/CO5280226A1/es not_active Application Discontinuation
- 2000-12-07 AR ARP000106541A patent/AR026764A1/es not_active Application Discontinuation
- 2000-12-08 AU AU25776/01A patent/AU782831B2/en not_active Expired
- 2000-12-08 RU RU2002118694/13A patent/RU2272419C2/ru active
- 2000-12-08 CN CNA2008101259037A patent/CN101327320A/zh active Pending
- 2000-12-08 MY MYPI20005779A patent/MY124714A/en unknown
- 2000-12-08 PL PL356175A patent/PL203054B1/pl unknown
- 2000-12-08 DK DK00989240.7T patent/DK1239872T3/da active
- 2000-12-08 IL IL15004800A patent/IL150048A0/xx unknown
- 2000-12-08 KR KR1020027007363A patent/KR100639746B1/ko active IP Right Review Request
- 2000-12-08 CA CA2394856A patent/CA2394856C/en not_active Expired - Lifetime
- 2000-12-08 JP JP2001543129A patent/JP4871473B2/ja not_active Expired - Lifetime
- 2000-12-08 AT AT00989240T patent/ATE481981T1/de active
- 2000-12-08 MX MXPA02005735 patent/MX264033B/es active IP Right Grant
- 2000-12-08 SK SK826-2002A patent/SK287956B6/sk not_active IP Right Cessation
- 2000-12-08 PT PT00989240T patent/PT1239872E/pt unknown
- 2000-12-08 HU HU0203402A patent/HU230301B1/hu unknown
- 2000-12-08 WO PCT/US2000/033466 patent/WO2001041785A2/en not_active Application Discontinuation
- 2000-12-08 CN CN00818851A patent/CN1433319A/zh active Pending
- 2000-12-08 US US09/731,971 patent/US6780628B2/en not_active Expired - Lifetime
- 2000-12-08 EP EP00989240A patent/EP1239872B1/en not_active Expired - Lifetime
- 2000-12-08 PH PH12000003381A patent/PH12000003381B1/en unknown
- 2000-12-08 NZ NZ519404A patent/NZ519404A/en not_active IP Right Cessation
- 2000-12-08 CZ CZ2002-2007A patent/CZ304925B6/cs not_active IP Right Cessation
- 2000-12-08 DE DE60045010T patent/DE60045010D1/de not_active Expired - Lifetime
- 2000-12-08 ES ES00989240T patent/ES2353371T3/es not_active Expired - Lifetime
- 2000-12-08 BR BRPI0016231A patent/BRPI0016231B8/pt not_active IP Right Cessation
- 2000-12-08 CN CN201110076924.6A patent/CN102172262B/zh not_active Expired - Lifetime
-
2001
- 2001-03-07 TW TW089126252A patent/TWI255189B/zh not_active IP Right Cessation
-
2002
- 2002-06-05 IL IL150048A patent/IL150048A/en active IP Right Grant
- 2002-06-06 IN IN585DE2002 patent/IN247731B/en unknown
- 2002-06-07 CR CR6674A patent/CR6674A/es unknown
-
2004
- 2004-05-28 US US10/855,416 patent/US7723091B2/en not_active Expired - Lifetime
-
2008
- 2008-01-09 CL CL200800057A patent/CL2008000057A1/es unknown
-
2013
- 2013-01-24 AR ARP130100218A patent/AR089799A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR026764A1 (es) | Tratamiento enzimatico para infecciones. | |
MY128071A (en) | Method for improving the skin and coat of pets | |
MY129662A (en) | Method for increasing pet activity | |
WO2005000161A3 (en) | Methods and devices for occluding body lumens and/or for delivering therapeutic agents | |
WO2005123116A3 (en) | Compositions and methods for treating or preventing oxalate-related disease | |
NO20023464D0 (no) | Sammensetning for intestinal avlevering | |
TR200102385T2 (tr) | Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları. | |
AU2002231889A1 (en) | Halogenated composition, method for preparing same and uses thereof | |
AU3555800A (en) | Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome | |
NO20011656L (no) | Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser | |
HK1047707A1 (zh) | (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途 | |
AR044271A1 (es) | Suplemento dietetico y metodo para el tratamiento y prevencion de ulceras en el tracto digestivo en equinos y otros animales | |
AR038355A1 (es) | Preparacion liofilizada que comprende inmunocitoquinas | |
EP1295611A4 (en) | COMPOUNDS FOR THE TRANSFER OF OLIGONUCLEOTIDES (03.01.02) | |
CN110506642A (zh) | 一种带粪便清理功能的饲养猪舍 | |
PL1853308T3 (pl) | Podawany drogą pokarmową preparat farmaceutyczny dla ryb, jego sposób wytwarzania oraz jego zastosowanie | |
AU2002220492A1 (en) | Method for inducing onset of the reproductive cycle of female breeding animals | |
ECSP003675A (es) | Metodo para aumentar la actividad de mascotas | |
Vasil'ev et al. | Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage) | |
RU2004111060A (ru) | Способ лечения и профилактики желудочно-кишечных инфекционных болезней поросят в условиях промышленного свиноводства | |
ECSP003646A (es) | Metodo para mejorar la piel y el pelaje de mascotas | |
MD2118G2 (ro) | Metodă balneologică de tratament al maladiilor dermatologice | |
UA33462A (uk) | Спосіб переміщення внутрішнього пахвинного кільця при крипторхізмі у дітей | |
IT1307903B1 (it) | Unguento ad azione terapeutica ed antisettica del derma animale,particolarmente a localizzazione podalica. | |
TH54151B (th) | การรักษาการติดเชื้อด้วยเอนไซม์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |